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Substance P and bombesm induce contraction of isolated IAS smooth muscle cells by 
different intracellular mechanisms. The cells contracted in a dose dependent manner to 
both peptides. The kinetics of contraction were different. Substance P induced 
contraction peaked at 30 seconds and declined in a time dependent manner while 
bombesm induced contraction peaked at 30 seconds and was maintained for up to 8 
minutes. The absence of extracellular calcium in the medium (0 calcium and 2 mM 
EGTA) had no affect on substance P induced contraction while it blocked bombesin 
induced contraction. Substance P induced contraction was blocked by the calmoduhn 
antagonist W7 (10-9M) and was not affected by the PKC antagonist H7 (10-6M). 
Bombesm induced contraction was blocked by the PKC antagonist H7 and was not 
affected by the calmodulin antagonist WT. Our data indicate that substance P induces a 
transient contraction utilizing intraceUular calcium and a calmodulin dependent pathway, 
while bombesin induces a sustained contraction utilizing calcium from extracellular 
sources and a calmodulin independent pathway. 
Substance P and bombesm have been described within the neuronal cell bodies of the human 
intestinal tract and are present in the rectosigmoid region of the human gut (1). The cell bodies 
project caudad to other neurons and muscle cells within the circular muscle layer (2,3). Substance 
P and bombesm have been shown to have direct myogenic action in a variety of tissues (4-8). 
There ~s evidence that binding of a contractile agonist to receptor sites on smooth muscle cells 
can follow the general pattern of stimulus-response coupling model for the phosphomositide 
cascade. Receptor activation of phospholipase C induces the hydrolysis of phosphatidylinositol 
4,5-biphosphate (PIP2) to form the intraeellular messengers Ins(1,4,5)-P3 and 1,2-DAG. 
Ins(1,4,5)-P3 (IP3) causes release of Ca++ sequestered within lntracellular stores and thereby 
elevates [Ca++]i. We have previously shown that CCK contracts human gastric smooth muscle 
cells through the utilization of intracellular Ca++ release and that IP3 mimics this contraction (9). 
Agonist induced contraction in smooth muscle has been shown to elevate IP3 (10). We have shown 
that exogenously added IP3 induces contraction of IAS ceils (11). 
The other metabolite of PIP2 hydrolysis, 1,2 diacylglycerol (1,2 DAG), acuvates protein 
klnase C (PKC) which has the ability to phosphorylate regulatory proteins and bring about a 
response that may be independent of the IP3-calmodulin pathway. PDB (a phorbol ester), which 
presumably stimulates PKC, has been shown to cause tonic contractile acnvity in arterial smooth 
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muscle which is associated w,th a pattern of phosphorylated proteins different from what is seen 
when acute phasic contraction occurs in this muscle (12). 
In the anorectal area the mtraceUular pathways mediating sustained and phas,c contractde 
actzvlty are not well defined. The aim of our study was to define the intracellular control mechanism 
responsible for mediating smooth muscle contraction in this region. Our data indicate that substance 
P reduced- transient contraction utilizes intracellular calcium stores and is mediated by a calmoduhn 
dependent pathway, whereas bombesin-induced sustained contracuon utilizes calcium from 
extracellular sources and is mediated via a calmodulin independent pathway. 
Methods 
The sphinctenc region was identified as previously described (13). After anesthesia, the 
pelvic bone is opened and a 5 cm segment containing the terminal portion of the colon and rectum, 
mcluding the anal sphincter, is measured and dissected free. The segment is opened with a nudhne 
incision along its anterior aspect, qmckly rinsed, and pinned on a wax block at its in vivo length. 
The txssue is kept immersed in oxygenated Kreb's solution on ice. The juncuon of the rectal 
mucosa with the skin lining the outer porUon of the canal is marked by sutures running through the 
whole thickness of the tissue; the external anal sphincter and the mucosa are removed by sharp 
dissection under a microscope, with care being taken not to disturb the sutures. Removal of the 
mucosa exposes the circular muscle layer, the circular fiber bundles are clearly visible. The internal 
anal sphincter, consisting of the distal most 3 mm of the circular muscle layer, ending at the junction 
of skin and mucosa, is removed by sharp dissection and dig.ested to yield isolated smooth muscle 
cells. 
The ceUs are isolated as previously described (14). The tissue is incubated for two successive 
60-mm periods at 31 ° C in 15 ml of HEPES buffer containing 0.1% collagenase (150 U/mg, 
Worthington CLS Type II) and 0.01% soybean trypsin inhibitor. At the end of the second 
enzymatac mcubation period, the medium is filtered out through 500-1am Nltex. The partly digested 
tissue left on the filter is washed four tames w,th 50 ml of collagenase-free buffer soluuon The 
ussue is then transferred into 15 ml of fresh buffer solulaon and incubated for 30 mm to allow the 
cells to disperse spontaneously. Only the cells that dissociate spontaneously in enzyme-free 
solution are used for functional stud,es. Cells are counted in a hemocytometer and dduted as 
needed. Each IAS yields 2-4 x 106 ceils. 
Muscle cells are examined vnthin 30 mm of dispersion. Aliquots consisting of 2.5 x 104 cells 
in 0 5 ml or reed,urn are added to 0.1 ml of a solutaon containing the test agents. In kinetic 
experiments the reaction is interrupted at various intervals (5 see to 8 rain) by the addition of 0.1 ml 
of acrolein at a final concentration of 1%. In experiments where dose-response characteristics are 
exanuned, the reaction is interrupted at the time of peak contractile response (30 see). Individual 
cell length is measured by computerized image micrometry. The average length of cells m the 
control state or after addition of test agents is obtained from 50 ceils encountered randomly m 
successive microscopic fields. The contractde response is defined as the decrease in the average 
length of the 50 cells and is expressed as the absolute change or the percent change from control 
length. W7 and H7 were obtained from Sexkagaku America Inc, St Petersburg FL, Collagenase 
(CLS Type II) was obtained from Worthington. All other materials were obtained from Sigma, St 
Louis MO. 
Results 
The response m Substance P was concentrauon-dependent (Fig. 1).A threshold response was 
attained at 10-riM, a half-maximal response was observed at 10 -9 M, and a maximal response was 
seen at 10-7M. Maximal response to Substance P by IAS cells was not sigmficantly different from 
the maximal response to Ach (35.7 + 1.2% versus 35.6 + 2.1% decrease m cell length from 
control). The same pattern of response was observed when IAS cells were stimulated with 
bombesm. The response was dose-dependent (Fig. 1) with a threshold dose for contraction at 
10-nM,  a half-maximal response observed at 10-8 M and a maximal response at 10-tM. The 
kinetics of contractaon of IAS cells in response to Substance P and bombesin are shown m Fig. 2 
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Substance P-induced contraction peaked at 30 see and then declined, while bombesin-induced 
contracuon peaked at 30 seconds and was sustained for up to 8 minutes. 
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The response of  smooth muscle cells from the IAS to bombesm and substance P. 
IAS ceils were incubated with the inchcated concentration of  either bombesin or 
substance P for 30 seconds. The data are shown as mean + SEM of 3 experiments 
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Figure 2 
IAS cells were incubated with (10 .6 M) substance P and bombesin for the indicated 
time. Substance P induced contraction peaks at 30 seconds and decreases m a time 
dependent manner. Bombesm induced contraction peaks at 30 seconds and remains 
elevated up to 8 tmnutes later. Data are expressed as mean + SEM of 3 experiments 
Preincubauon of  these cells for 60 seconds Wlth the calmodulin antagomst W7 (10-9M) blocked 
maximal substance P-induced contraction, but had no effect on bombesin-induced contraction 
(Fig. 3). Preincubation of  the cells for 60 seconds with the PKC antagonist H7 (10-6M) blocked 
the bombesin-lnduced contraction and had no effect on the substance P-induced contractxon 
(Fig. 3) 
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Figure 3 
Bombesin (10 .6 M) induced contraction of  IAS isolated smooth muscle cells is blocked by 
the Protein Kinase C antagonist H7 (10 -6 M), but is not affected by the calmodulin antagomst 
W7 (10 -9 M ) .  Conversely, substance P (10 -6 M) reduced contraction is blocked by W7 and 
not by HT. Data are expressed as mean + SEM of 3 experiments. 
It has been established that changes m cytosolic calcmm [Ca~]~ are associated with changes in 
the contractile state of  smooth muscle. The role of  calcium in generating a brief "phasic" or a 
sustained "tonic" contraction is important. Our data from isolated cells of the rabbit IAS suggest 
that substance P and bombesin preferentially utilize different sources of  ca lcmm to induce 
contracuon. Substance P utilizes Ca ++ released from mtraceUular stores, as substance P induced 
contractaon is not affected by incubation in Ca++-free medium ( 0 Ca++/2 mM EGTA) or by Ca++ 
channel blockers. Bombesm utihzes reflux of extracellular Ca ++ as bombesm-induced contracuon ~s 
blocked under the same circumstances (Fig. 4). These data suggest that agonist induced contraction 
m the same muscle may utilize discrete sources of  Ca++ and thus provide a further possible 
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Figure 4 v 
Response of  isolated cells from IAS to (10 .6 M) bom~s~n and substance P in normal 
buffer and in the absence of  extracellular Ca ++ with 2 mM EGTA. Data are expressed 
as + the SEM of 3 experiments. 
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Discussion 
Substance P and bombesin have been described to be contained within the neuronal cell bodies 
of the human intestinal tract, do not have projections into the epithelial cells (15) and are present m 
the rectomgmoid (1). They have been shown to have direct myogemc action in a variety of ussues 
(4-8). The purpose of this investiganon is to deternune the effect and mode of action of these two 
pept~des in the anal sphincter, and to examine their Interaction in producing contraction and 
maintenance of tone. 
The IAS is characterized by the ability to maintain tone, and to relax allowing the passage of 
feces. IAS tone is thought to be spontaneous and regulated predominantly through myogenic 
mechanisms (16-19). IP3 mediated release of intracellular Ca++ leads to activation of Ca++ 
sensitive proteins, such as a calmodulin-dependent protein kinase, which causes contracuon via the 
phosphorylation of specifie sites on the 20,000 dalton myosin light chain (20-25) The other 
Ptdlns(4,5)P2 metabolite, 1,2 diacylglycerol, can activate Protein Kinase C (PKC) which has the 
ability to phosphorylate regulatory proteins and bring about responses that may be independent of 
the Ins(1,4,5)P3/calmoduhn pathway. 
In IAS ceils the addiuon of either exogenous Ins(1,4,5)P3 or PKC causes shortening in a 
dose-dependent manner (11) that is sirmlar in efficacy, but is selectively inhibited by W7 in the 
case of Ins(1,4,5)P3 and by H7 in the case of PKC. The tmae course of IAS cell contraction that is 
seen with Ins(1,4,5)P3 shows a peak response at 5 seconds and then decreases in a time dependent 
manner. PKC-induced contracuon is slower in developing, peaking at thirty seconds and remains 
elevated for up to eight minutes. The different kinetics and sensitivity to antagomsts suggests that 
IP3 and PKC mediated contraction follow distinct intracellular pathways. 
Our data indicate that substance P-induced contraction of the internal anal sphincter similar to 
exogenous IP3, may be mediated by intracellular Ca ++ release through a calmodulin dependent 
pathway, while bombesin-induced contraction is dependent on Cam from extracellular sources and 
a PKC mediated, calmodulin-independent pathway (Fig. 3). The kinetics of contraction induced 
by bombesin and exogenously added PKC are similar but differ from contraction induced by 
substance P or exogenously added IP3. The contractions in response to substance P and IP3 are 
transient, peaking rapidly and then declining, while the contraeuons induced by bombesin and 
PKC develop more slowly and persist for a prolonged period. The sustained contraction observed 
in ~solated cells may reflect tonic contraction m vivo. It is possthle that tone may not be totally 
dependent upon Ca ++ release from intracellular stores and is dependent on PKC in a manner sim:lar 
to what is seen in the tonic contraction observed with PKC activators (26-30). 
The existence of distract mechanisms in the same cell implies that depending on the receptors 
activated by different agonists, different proporuons of IP3 or DAG may be produced. The data 
are conmstent with the hypothems that bombesin may activate almost exclusively phospholipases 
responsible for formation of DAG, possibly by hydrolysing phosphatidylcholine (PC), without 
production of IP3 (31-33). 
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